A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co. [View article]
It is hard to judge what is hot, cold and what could blow up in your face.
I have all three as well as Merck, Schering-Plough, Aventis and Novartis. Like insurance and finance - pharma is inherently risky - apart from pipeline and patent (expiry, litigation) risks, there is product risk (i.e. Vioxx) as well as the massive investments needed to bring a product to the market.
Best is to buy a basket of top Pharma/Biotech - with strong dividends and diversity - they are not a bad investment in the long run with the aging population and the start of the genomic revolution ...
-
It is hard to judge what is hot, cold and what could blow up in your face.
Sep 28 14:13 pm
|Rating:
0
0
All Comments by E Nuff Sed »A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co. [View article]
I have all three as well as Merck, Schering-Plough, Aventis and Novartis. Like insurance and finance - pharma is inherently risky - apart from pipeline and patent (expiry, litigation) risks, there is product risk (i.e. Vioxx) as well as the massive investments needed to bring a product to the market.
Best is to buy a basket of top Pharma/Biotech - with strong dividends and diversity - they are not a bad investment in the long run with the aging population and the start of the genomic revolution ...